Michael S Rafii
Works at
University of Southern California
Professor
Sources: reporter.nih.gov
Grants and prizes
R01, Life’s end Benefits of CannaBidiol and TetrahYdrocannabinol (LiBBY) Open-Label Extension (OLE) Study, R01AG095004, 2025–2028, 19 Aug 2026
R01, Precision Medicine for Inflammatory Treatment for Alzheimer's Disease in Down Syndrome, R01AG073979, 2021–2026, 7 Aug 2025
R33, Clinical trials to prevent Alzheimer's Disease in Down Syndrome, R33AG066543, 2019–2026, 22 Aug 2024
Sources: reporter.nih.gov